Maryland Oncology Hematology — Rockville, Maryland

Maryland Oncology Hematology is a clinical research site located in Rockville, Maryland, United States 20850.

Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

Maryland Oncology Hematology has participated in 13 clinical trials with 4 currently active.

Therapeutic areas: Metastatic Castration Resistant Prostate Cancer (mCRPC), SARS-CoV-2 Infection, Ovarian Cancer.

Sponsors: Constellation Pharmaceuticals, MediMergent, LLC, Sutro Biopharma, Inc..

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Maryland Oncology Hematology?

Maryland Oncology Hematology has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Maryland Oncology Hematology conducted?

Maryland Oncology Hematology has 13 clinical trials on record, with 4 currently active. Their work covers Metastatic Castration Resistant Prostate Cancer (mCRPC), SARS-CoV-2 Infection, Ovarian Cancer.

Is Maryland Oncology Hematology accredited by Crixeo Health?

Maryland Oncology Hematology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Maryland Oncology Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.